Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS other · 2026-04-15

Clinical Trial Update: Study of Zelenectide Pevedotin in Participants With Advanced Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 study of Zelenectide Pevedotin in advanced breast cancer is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zelenectide Pevedotin

Snippet

Sponsor: BicycleTx Limited | Conditions: Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING